Table 1.
Characteristics of 171 patients with differentiated thyroid cancer in this study.
| Variables | All (n = 171) | No recurrence (n = 114) | Recurrence (n = 57) | P value |
|---|---|---|---|---|
| Age (years) | 48.5 ± 14.2 | 48.3 ± 13.5 | 48.9 ± 15.7 | 0.802 |
| Sex | 0.902 | |||
| Male | 44 (26%) | 29 (25%) | 15 (26%) | |
| Female | 127 (74%) | 85 (75%) | 42 (74%) | |
| Body mass index (kg/m2) | 24.3 ± 3.8 | 24.0 ± 3.7 | 24.9 ± 4.0 | 0.146 |
| BMI category | 0.049 | |||
| Underweight | 5 (3%) | 2 (2%) | 3 (5%) | |
| Normal | 86(50%) | 65 (57%) | 21 (37%) | |
| Overweight | 42 (25%) | 26 (23%) | 16 (28%) | |
| Obesity | 38 (22%) | 21 (18%) | 17 (30%) | |
| TNM stage | 0.605 | |||
| Stage I | 82 (48%) | 56 (49%) | 26 (46%) | |
| Stage II | 7 (4%) | 3 (3%) | 4 (7%) | |
| Stage III | 28 (16%) | 19 (17%) | 9 (16%) | |
| Stage IV | 54 (32%) | 36 (32%) | 18 (32%) | |
| Hypertension | 0.411 | |||
| No | 119 (70%) | 77 (68%) | 42 (74%) | |
| Yes | 52 (30%) | 37 (32%) | 15 (26%) | |
| Diabetes mellitus | 0.874 | |||
| No | 148 (87%) | 99 (87%) | 49 (86%) | |
| Yes | 23 (13%) | 15 (13%) | 8 (14%) | |
| Hyperlipidemia | 0.599 | |||
| No | 134 (78%) | 88 (77%) | 46 (81%) | |
| Yes | 37 (22%) | 26 (23%) | 11 (19%) | |
| Family history | 0.206 | |||
| No | 154 (90%) | 105 (92%) | 49 (86%) | |
| Yes | 17 (10%) | 9 (8%) | 8 (14%) | |
| Total symptom score | 3.0 ± 1.7 | 2.4 ± 1.4 | 4.0 ± 1.7 | <0.001 |
| Pharyngolaryngeal | 1.3 ± 1.2 | 1.1 ± 1.0 | 1.9 ± 1.3 | <0.001 |
| Psychoneurological | 1.3 ± 1.2 | 1.1 ± 1.1 | 1.7 ± 1.3 | 0.005 |
| Gastrointestinal | 0.2 ± 0.5 | 0.2 ± 0.4 | 0.3 ± 0.6 | 0.264 |
Abbreviations: BMI, body mass index; TNM, tumor-node-metastasis.